
Acorda Therapeutics
#8700
Rank
$821.03K
Marketcap
United States
Country

Dr. Ron Cohen M.D. (Founder, CEO, Pres & Director)
Dr. Burkhard Blank M.D. (Interim Head of Drug Safety)
Mr. Michael A. Gesser M.B.A. (Chief Financial Officer)
Summary
History
Acorda Therapeutics is a pharmaceutical company that was founded in 1995. The company is dedicated to developing novel therapies that restore and reverse neurological deficits, improve coordination and functioning, and reduce pain. Acorda has reached success with proprietary treatments for multiple sclerosis that are taken orally and provide greater efficacy to patients than previous therapies.
Mission
Vision
Key Team
Mr. Robert Morales (Interim Principal Accounting Officer, Principal Financial Officer, VP of Fin. & Controller)
Ms. Tierney Saccavino (Exec. VP of Corp. Communications)
Ms. Felicia Vonella (VP of Investor Relations)
Mr. Neil S. Belloff Esq. (Gen. Counsel & Corp. Sec.)
Mr. Andrew Mayer J.D. (Sr. VP)
Ms. Denise J. Duca (Exec. VP of HR)
Mr. Kerry M. Clem (Chief Commercial Officer)
Recognition and Awards
References
https://en.wikipedia.org/wiki/Acorda_Therapeutics
https://in.investing.com/equities/acorda-therapeutics
https://finance.yahoo.com/quote/ACOR/profile?p=ACOR
https://www.comparably.com/companies/acorda-therapeutics/mission
https://www.crunchbase.com/organization/acorda-therapeutics
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Dr. Ron Cohen M.D. (Founder, CEO, Pres & Director)
Dr. Burkhard Blank M.D. (Interim Head of Drug Safety)
Mr. Michael A. Gesser M.B.A. (Chief Financial Officer)
